COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE is a Public Limited Company registered in France under 49326528400015, and its current status with INPI (Institut National de la Propriété Industrielle) is active. The company was incorporated on 4 December 2006 and lists its registered address as ROUEN, France. 1 shareholder is on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last updated on 1 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE, held on the statuts (articles of association) and filed corporate acts, filed under the Code de commerce.
The largest of these is Olivier Bronchain, holding 100% — a majority holding.
The shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Olivier Bronchain | 100% | INPI (Institut National de la Propriété Industrielle) |
Officers
5
The Chief Executive Officer of COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE currently on record is Marc Marcel Hoeschen; five officers are currently on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE, filed with INPI (Institut National de la Propriété Industrielle).
The register reports 15 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span France, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE
France
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE?
One shareholder is currently on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE, held on the statuts (articles of association) and filed corporate acts, filed under the Code de commerce. The largest of these is Olivier Bronchain, holding 100% — a majority holding. The shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
Who is COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE have on record?
1 shareholder is shown on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE.
What is COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's company registration number?
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's registration number is 49326528400015, filed with INPI (Institut National de la Propriété Industrielle) in France. Its current status on the register is active.
Is COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE still an active company?
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's status on INPI (Institut National de la Propriété Industrielle) is listed as active.
When was COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE incorporated?
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE was incorporated on 4 December 2006, according to INPI (Institut National de la Propriété Industrielle).
What is COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's registered address?
The registered address on file for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE is ROUEN, France.
What legal structure is COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE registered as?
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE is registered as a Public Limited Company in France.
Who are the officers/directors of COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE?
The Chief Executive Officer of COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE currently on record is Marc Marcel Hoeschen; five officers are currently on record for COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE, filed with INPI (Institut National de la Propriété Industrielle). Management authority at COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE have a parent company or subsidiaries?
COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span France, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's ownership over time?
This profile reflects a point-in-time snapshot from INPI (Institut National de la Propriété Industrielle). Zavia's monitoring API can track changes to COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including France, so records like COMPAGNIE D’EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last synced on 1 October 2026.